CIPLA's weekly performance was disappointing, with a return of -2.09% and a Sharpe Ratio of -1.13, indicating poor risk-adjusted returns. The stock's volatility was relatively low at 9.8%, but still underperformed its peers, with SUNPHARMA and DIVISLAB experiencing smaller losses. GRASIM, however, fared worse with a return of -2.17%. Overall, CIPLA was a relatively low-risk stock this week, but its poor performance dragged it down.

[Volatility: 9.8%]